WAYS TO VERIFY NONALCOHOLIC FATTY LIVER DISEASE

Download full text PDF
Issue: 
10
Year: 
2015

P. Seliverstov (1), Candidate of Medical Sciences; E. Prikhodko (1); Professor V. Radchenko (1), MD; Professor L. Oreshko (1), MD; S. Sitkin (1) Candidate of Medical Sciences; Sh. Adylov (2); Professor Yu. Yurkevich (2), MD; O. Supilnikova (2) 1 -I.I. Mechnikov North-Western State Medical University, Saint Petersburg 2 -Pokrovsky Stem Cell Bank, Saint Petersburg

Nonalcoholic fatty liver disease has become an interdisciplinary problem. Time diagno-sis and identification of risk factors favoring the development of the disease prevent its further progression.
Keywords: 
liver
steatohepatitis
telomeres
diagnosis

It appears your Web browser is not configured to display PDF files. Download adobe Acrobat или click here to download the PDF file.

References: 
  1. Bogomolov P.O., Shul'pekova Ju.O. Steatoz pecheni i nealkogol'nyj steatogepatit. V kn.: Bolezni pecheni i zhelchevyvodjaschih putej. Izd. 2-e. Pod red. V.T. Ivashkina, 2005; s. 205–16.
  2. Bueverov A.O., Bogomolov P.O. Nealkogol'naja zhirovaja bolezn' pecheni: obosnovanie patogeneticheskoj terapii // Klin. perspektivy v gastroente-rol., gepatol. – 2009; 1: 3–9.
  3. Drapkina O.M., Smirin V.I., Ivashkin V.T. Nealkogol'naja zhirovaja bolezn' pecheni – sovremennyj vzgljad na problemu // Lechaschij vrach. – 2010; 5 (5): 57–61.
  4. Pavlov Ch.S., Zolotarevskij V.B., Ivashkin V.T. i dr. Struktura hroniche-skih zabolevanij pecheni po dannym biopsii i morfologicheskogo issledo-vanija ee tkani // Ros. zhurn. gastroenterol., gepatol., koloproktol. – 2007; 17 (1): 90.
  5. Lazebnik L.B., Zvenigorodskaja L.A., Mel'nikova N.V. i dr. Aterogennaja dislipidemija i insulinorezistentnost', assotsiirovannye s nealkogol'noj zhirovoj bolezn'ju pecheni (shodstva i razlichija), differentsirovannyj pod-hod k terapii // Kardiovask. ter. i profilakt. – 2009; 3: 69–77.
  6. Pavlov Ch.S., Zolotarevskij V.B., Ivashkin V.T. i dr. Biopsija i morfo-logicheskoe issledovanie v diagnostike hronicheskih zabolevanij pecheni neutochnennoj etiologii // Ros. zhurn. gastroenterol., gepatol., koloproktol. – 2007; 17 (1): 90.
  7. Seliverstov P.V., Radchenko V.G. Nealkogol'naja zhirovaja bolezn'peche-ni, novye vozmozhnosti terapii // Med. al'manah. – 2014; 1: 38–40.Seliverstov P.V., Nealkogol'naja zhirovaja bolezn' pecheni: ot teorii k praktike // Arhiv vnutrennej meditsiny. – 2015; 1 (21): 19–26.
  8. Jakovenko E.P. Agafonova N.A., Grigor'eva V.P. i dr. Metabolicheskie zabolevanija pecheni: nealkogol'nyjsteatoz i steatogepatit. Diagnostika i lechenie // Kachestvo zhizni. Meditsina. – 2004; 2 (5): 53–9.
  9. Bellentasi S., Saccoccio G. et al. Prevalence of and risk factors for hepatic steatosis in nothern Italy // Ann. Intern. Med. – 2000; 132 (2): 112–7.
  10. Dongiovanni P., Valenti L., Rametta R. et al. Genetic variants regulating insulin receptor signalling are associated with the severity of liver damage in patients with non-alcoholic fatty liver disease // Gut. – 2010; 59: 267–73.
  11. Donnelly K., Smith C., Schwarzenberg S. et al. Sources of fatty acids stored in liver and secreted via lipoproteins in patients with non-alcoholic fatty liver disease // J. Clin. Invest. – 2005; 115 (5): 1343–51.
  12. James O., Leuschner U., James O., Dancygier H. (eds.) Diagnosis of non–alcoholic steatohepatitis. In: Steatohepatitis (Nash and ASH) / Dordrecht: Kluwer Academic Publishers, 2001; 34–9.
  13. Neuschwander-Tetri B., Brunt E., Wehmeier K. et al. Improved non–alcoholic steatohepatitis after 48 weeks of treatment with the PPAR–gamma ligand rosiglitazone // Hepatology. – 2003; 38 (4): 1008–17.
  14. Kitada T., Seki S., Kawakita N. et al. Telomere shortening in chronic liver diseases // Biochem. Biophys. Res. Commun. – 1995; 211: 33–9.
  15. Urabe Y., Nouso K., Higashi T. et al. Telomere length in human liver diseases // Liver. – 1996; 16: 293–7.
  16. Aikata H., Takaishi H., Kawakami Y. et al. Telomere reduction in human liver tissues with age and chronic inflammation // Exp. Cell. Res. – 2000; 256: 578–82
  17. Chang Y., Ryu S., Sung E. et al. Weight gain within the normal weightrange predicts ultrasonographically detected fatty liver in healthy Korean men // Gut. – 2009; 58: 1419–25.